Table 1.
Baseline characteristics
| Characteristic | Value |
|---|---|
| Age (year) | 70.2 ± 8.0 |
| Male/female (n) | 6/0 |
| Underlying disease, n (%) | |
| Diabetic kidney disease | 4 (66.7) |
| Nephrosclerosis | 2 (33.3) |
| Hemodialysis duration (months) | 72.5 ± 40.4 |
| Comorbidity, n (%) | |
| Ischemic heart disease | 5 (83.3) |
| Stroke | 0 (0) |
| Hypertension | 6 (100) |
| Diabetes | 5 (83.3) |
| Dyslipidemia | 3 (50.0) |
| Smoking habit, n (%) | |
| No | 2 (33.3) |
| Ex | 4 (66.7) |
| Body mass index (kg/m2) | 22.9 ± 1.9 |
| Cardiac function | |
| LVEF (%) | 55.5 ± 7.3 |
| LVMI (g/m2) | 154.3 ± 38.7 |
| E/e’ | 16.9 ± 8.4 |
| Laboratory variables | |
| Blood urea nitrogen (mg/dl) | 41.3 ± 9.2 |
| Creatinine (mg/dl) | 8.5 ± 2.2 |
| Total protein (g/dl) | 6.6 ± 0.8 |
| Albumin (g/dl) | 3.7 ± 0.4 |
| Total cholesterol (mg/dl) | 145.2 ± 24.3 |
| Triglyceride (mg/dl) | 134.3 ± 45.9 |
| HDL cholesterol (mg/dl) | 54.0 ± 13.5 |
| LDL cholesterol (mg/dl) | 63.8 ± 21.1 |
| C‐reactive protein (mg/dl) | 0.75 ± 1.12 |
| Hemoglobin (g/dl) | 11.4 ± 1.7 |
| Hemoglobin A1c (%) | 6.9 ± 1.6 |
| Medication, n (%) | |
| Aspirin | 5 (83.3) |
| Clopidogrel | 4 (66.7) |
| Serotonin 5HT2 antagonist | 1 (16.7) |
| Cilostazol | 2 (33.3) |
| Prostanoid | 3 (50.0) |
| Statin | 4 (66.7) |
| ARB | 3 (50.0) |
Abbreviations: ARB, accumulative roll bonding; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index.